Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
JUNTEN BIO logo — JUNTEN BIO is a company is to develop new technologies in th...

JUNTEN BIO

JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.

Founded 2018 4 employees Corporate Round Total: $1.65B Biotechnology

General Information

Company Name JUNTEN BIO
Founded Year 2018
Employees 4
Industries Biotechnology
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with JUNTEN BIO. To contact JUNTEN BIO, visit juntenbio.co.jp.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About JUNTEN BIO

Junten Bio is a biotechnology startup founded in 2018, with a focus on developing new technologies in the field of regenerative medicine. The company received a significant ¥200.00M corporate round investment on 04 June 2019 from Fujifilm, signifying a strong show of confidence from a major player in the industry. With this infusion of capital, Junten Bio is poised to further its mission of advancing regenerative medicine and solidify its position as an innovative leader in this rapidly evolving sector.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round ¥200.00M 1
Fujifilm
Fujifilm
04 Jun 2019
Venture Round ¥1.45B 5
Daiwa Corporate Investment Sosei CVC BiGEN
Daiwa Corporate Investment, Sosei CVC +3
17 Dec 2018

JUNTEN BIO Alternatives & Competitors

View All Alternatives
JUNTEN BIO vs
Global Regenerative Group Inc.
Global Regenerative Group Inc. United States

Global Regenerative Group is a fast-growing company bringing science into practice at the field of R...

6 employees
Biotechnology, Health Care
JUNTEN BIO vs
Eliksa Therapeutics
Eliksa Therapeutics United States

The Future of Regenerative Medicine

6 employees
Biotechnology
JUNTEN BIO vs
REV-MED Inc.
REV-MED Inc. Korea South

Innovating regenerative medicine and bioengineering technologies for a healthier future

7 employees
Biotechnology, Health Care
View all alternatives

FAQ About JUNTEN BIO

JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
JUNTEN BIO was founded in 2018.
JUNTEN BIO operates in Biotechnology.
JUNTEN BIO has approximately 4 employees.
JUNTEN BIO has completed 2 funding rounds, raising a total of $1.65B. The latest funding stage is Corporate Round.
Top alternatives and competitors to JUNTEN BIO include Global Regenerative Group Inc., Eliksa Therapeutics, REV-MED Inc., TENSIVE SRL, Gel4Med, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
JUNTEN BIO and Global Regenerative Group Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for JUNTEN BIO, https://bouncewatch.com/company/junten-bio, updated 19 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes